ROLE OF DENDRITIC CELLS IN REGULATING VACCINE- INDUCED IMMUNITY AGAINST Q FEVER

树突状细胞在调节疫苗诱导的 Q 热免疫中的作用

基本信息

  • 批准号:
    10049108
  • 负责人:
  • 金额:
    $ 12.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-05-15 至 2021-04-30
  • 项目状态:
    已结题

项目摘要

Abstract Coxiella burnetii is an obligate intracellular Gram-negative bacterium that causes acute and chronic Q fever in humans. There is an urgent need to create a safe and effective vaccine for prevention of human Q fever. However, the mechanisms of vaccine-induced immunity against C. burnetii natural infection remain unclear. The long-term goal of this project is to develop a safe and effective vaccine against Q fever. The objective of this application, which is a critical step towards this goal, is to understand the role of dendritic cells (DCs) in regulating vaccine-induced immunity against Q fever and identify which type of T cell response is more critical for vaccine-induced protective immunity. To achieve this objective, two specific aims were proposed to test the central hypothesis that C. burnetii phase I vaccine (PIV) and phase II vaccine (PIIV) differentially activate DCs, thereby promoting distinct T cell responses are responsible for the difference in their ability to confer protection. Aim 1 will determine the role of DCs in regulating vaccine-induced immunity against Q fever by examining i) if PIV and PIIV differentially activate DCs, thereby promoting distinct T cell differentiation patterns in a mouse model; and ii) if DCs play a role in vaccine-induced protection against C. burnetii aerosol infection in vivo. Aim 2 will determine the role of CD4+ T cell subsets in PIV-induced protective immunity against C. burnetii aerosol infection by using a mouse model to investigate i) if PIV- and PIIV-induced T cell responses are responsible for the difference in their ability to confer protection; and ii) which CD4+ subset T cell response is more critical for PIV-induced protection. As an outcome of this research, it will gain novel information for understanding the role of DCs in regulating T cell-mediated immunity and determining the role of T cell responses in vaccine-induced protective immunity against C. burnetii infection. This is expected to have significant positive effects on publich health, because it will provide critical information for developing a safe and effective vaccine against Q fever.
摘要 伯氏柯克斯体是一种专性细胞内革兰氏阴性细菌,可引起急性和慢性Q热。 人类。迫切需要创造一种安全有效的疫苗来预防人类Q热。 然而,疫苗诱导免疫抵抗伯氏梭菌自然感染的机制尚不清楚。 该项目的长期目标是开发一种安全有效的Q热疫苗。的目标是 这一应用是实现这一目标的关键一步,目的是了解树突状细胞(DC)在 调节疫苗诱导的免疫对抗Q热,并确定哪种类型的T细胞反应更关键 疫苗诱导的保护性免疫。为了实现这一目标,提出了两个具体目标来测试 中心假设伯氏弧菌I期疫苗(PIV)和II期疫苗(PIIV)具有不同的激活作用 DC,从而促进不同的T细胞反应是它们授予能力的差异的原因 保护。目的1确定树突状细胞在调节疫苗诱导的Q热免疫中的作用 检查一)PIV和PIIV是否以不同方式激活DC,从而促进不同的T细胞分化模式 在小鼠模型中;以及ii)树突状细胞是否在疫苗诱导的预防伯氏梭菌气溶胶感染中发挥作用 在活体内。目的2确定CD4+T细胞亚群在PIV诱导的保护性免疫中的作用。 用小鼠模型研究伯氏杆菌气溶胶感染:1)PIV和PIIV是否诱导T细胞反应 它们提供保护的能力的不同;以及ii)哪些CD4+T细胞亚群反应 对于PIV诱导的保护更为关键。作为这项研究的结果,它将获得新的信息 了解树突状细胞在调节T细胞免疫中的作用和确定T细胞的作用 疫苗诱导对伯氏梭菌感染的保护性免疫应答。预计这将会有 对公众健康的重大积极影响,因为它将为制定安全的 以及有效的Q热疫苗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Guoquan Zhang其他文献

Guoquan Zhang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Guoquan Zhang', 18)}}的其他基金

Mechanisms of B-1 Cell-Mediated Immunity Against Coxiella burnetii Infection
B-1细胞介导的伯氏柯克斯体感染免疫机制
  • 批准号:
    10155409
  • 财政年份:
    2020
  • 资助金额:
    $ 12.48万
  • 项目类别:
IDENTIFY NOVEL NEUTRALIZATION-SENSITIVE EPITOPES OF COXIELLA BURNETII
鉴定伯内特丘克斯体的新型中和敏感表位
  • 批准号:
    10020119
  • 财政年份:
    2019
  • 资助金额:
    $ 12.48万
  • 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
  • 批准号:
    10207396
  • 财政年份:
    2018
  • 资助金额:
    $ 12.48万
  • 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
  • 批准号:
    10005679
  • 财政年份:
    2018
  • 资助金额:
    $ 12.48万
  • 项目类别:
Use of a Humanized Antibody against Intracellular Bacterial Pathogen
抗细胞内细菌病原体的人源化抗体的用途
  • 批准号:
    10003580
  • 财政年份:
    2018
  • 资助金额:
    $ 12.48万
  • 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
  • 批准号:
    9982219
  • 财政年份:
    2018
  • 资助金额:
    $ 12.48万
  • 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
  • 批准号:
    9762833
  • 财政年份:
    2018
  • 资助金额:
    $ 12.48万
  • 项目类别:
Development of O Antigen-based Vaccines Against Q Fever
基于 O 抗原的 Q 热疫苗的开发
  • 批准号:
    8582500
  • 财政年份:
    2010
  • 资助金额:
    $ 12.48万
  • 项目类别:
Development of O Antigen-based Vaccines Against Q Fever
基于 O 抗原的 Q 热疫苗的开发
  • 批准号:
    8386914
  • 财政年份:
    2010
  • 资助金额:
    $ 12.48万
  • 项目类别:
Development of O Antigen-based Vaccines Against Q Fever
基于 O 抗原的 Q 热疫苗的开发
  • 批准号:
    8197349
  • 财政年份:
    2010
  • 资助金额:
    $ 12.48万
  • 项目类别:

相似海外基金

AEROSOLS
气雾剂
  • 批准号:
    10101317
  • 财政年份:
    2024
  • 资助金额:
    $ 12.48万
  • 项目类别:
    EU-Funded
AEROSOLS - AIR QUALITY AND HEALTH IMPACT OF PRIMARY SEMI-VOLATILE AND SECONDARY PARTICLES AND THEIR ABATEMENT
气溶胶 - 一次半挥发性颗粒和二次颗粒对空气质量和健康的影响及其消除
  • 批准号:
    10092043
  • 财政年份:
    2024
  • 资助金额:
    $ 12.48万
  • 项目类别:
    EU-Funded
Molecular-level Understanding Of Atmospheric Aerosols (MUOAA 2024); Corsica, France; April 1-5, 2024
对大气气溶胶的分子水平理解(MUOAA 2024);
  • 批准号:
    2332007
  • 财政年份:
    2024
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Standard Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
  • 批准号:
    NE/Y000021/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Research Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
  • 批准号:
    NE/Y000358/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Research Grant
Southern Ocean aerosols: sources, sinks and impact on cloud properties
南大洋气溶胶:来源、汇以及对云特性的影响
  • 批准号:
    DP240100389
  • 财政年份:
    2024
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Discovery Projects
INvestigating Home water and Aerosols' Links to opportunistic pathogen Exposure (INHALE): do consumer decisions impact pathogen exposure and virulence?
调查家庭用水和气溶胶与机会性病原体暴露(吸入)的联系:消费者的决定是否会影响病原体暴露和毒力?
  • 批准号:
    2326096
  • 财政年份:
    2023
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Standard Grant
An AI-driven clinical washbasin unit that automatically disinfects pathogens, reduces aerosols and decreases healthcare-acquired infections by 70%
%20人工智能驱动%20临床%20洗脸盆%20单位%20%20自动%20消毒%20病原体,%20减少%20气溶胶%20和%20减少%20医疗保健获得性%20感染%20by%2070%
  • 批准号:
    83001507
  • 财政年份:
    2023
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Innovation Loans
Cloudbusting with JWST: characterising aerosols, aurorae and chemistry in substellar atmospheresto the water cloud regime
使用 JWST 进行云消除:描述水云状态下恒星大气中的气溶胶、极光和化学成分
  • 批准号:
    ST/X001091/1
  • 财政年份:
    2023
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Research Grant
Bioactivated Aerosols for Combustion Product Capture
用于燃烧产物捕获的生物活性气溶胶
  • 批准号:
    10080253
  • 财政年份:
    2023
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Small Business Research Initiative
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了